Sanguine BioSciences is a biotechnology company structured to address bridging the gap between patients and researchers developing personalized medicine. Directly challanging the tradition model for clinical trials, the Sanguie approach is to bring those clinical trials into the home. From the premise that it should be easy for patients to contribute to the advancement of research for medical conditions that matter most to them, regardless of their location or ability to travel by bringing health care professionals to the home, the firm's proprietary platform seamlessly integrates information from site/sponsor, mobile clinical staff, and patients, increasing efficiency, consistency, and quality for each at-home visit. The firm's mobile staff cover the US, Canada and Europe. With each staffer trained on specific protocols and carrying the credentials that are necessary in conducting clinical trial procedures at the patient's home, the effort is to widen patient reach for improved recruitment, decrease patient burden for improved retention, and decrease site-work effort.